Trials / Completed
CompletedNCT00609596
A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.
An Open Label, Randomized, Repeat Dose, 3 Period Crossover Study to Determine the Bioequivalence of 3 Different Formulations of Tamsulosin at Steady State in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Dutasteride and tamsulosin are to treat benign prostatic hyperplasia. Studies show that when given together, there is more improvement in symptoms than either drug alone. In this study, we are looking to see if 2 different formulations of tamsulosin in our combination capsules are the same after 7 days of dosing as the US commercial tamsulosin and dutasteride.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GI198745 |
Timeline
- Start date
- 2008-02-26
- Primary completion
- 2008-04-23
- Completion
- 2008-04-23
- First posted
- 2008-02-07
- Last updated
- 2017-08-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00609596. Inclusion in this directory is not an endorsement.